Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada

被引:10
|
作者
Chaudhry, Ahsan [1 ,2 ]
Bastien, Nathalie [3 ]
Li, Yan [3 ]
Scott, Allison [4 ]
Pabbaraju, Kanti [5 ]
Stewart, Douglas [1 ,2 ]
Wong, Sallene [5 ]
Drews, Steven J. [6 ,7 ]
机构
[1] Univ Calgary, Dept Oncol, Calgary, AB, Canada
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Natl Microbiol Lab, Winnipeg, MB, Canada
[4] Surveillance & Assessment Accountabil & Performan, Edmonton, AB, Canada
[5] ProvLab Alberta Calgary, Calgary, AB, Canada
[6] ProvLab Alberta Edmonton, Edmonton, AB, Canada
[7] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada
关键词
H3N2; influenza; neuraminidase inhibitors; reduced susceptibility; resistance; sequence analysis; NEURAMINIDASE INHIBITORS; SUSCEPTIBILITY; ASSAYS;
D O I
10.1111/irv.12415
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This manuscript describes the identification of an oseltamivir-resistant influenza A (H3N2) virus in a respiratory specimen collected from an immunocompromised patient in Alberta, Canada, during the 2014-2015 influenza season. Following treatment with oseltamivir, neuraminidase (NA) gene sequencing indicated the presence of an R292K mutation. Phenotypic susceptibility testing by the NA-Star assay indicated a highly reduced inhibition by oseltamivir and normal inhibition by zanamivir. The use of zanamivir following identification of the oseltamivir-resistant strain, combined with a partial immune reconstitution, was followed by a suggested decrease in the nasopharyngeal viral load in the nasopharynx and clinical improvement of the patient.
引用
收藏
页码:532 / 535
页数:4
相关论文
共 50 条
  • [1] Antigenic variation of the human influenza A (H3N2) virus during the 2014-2015 winter season
    Hua Sha
    Li XiYan
    Liu Mi
    Cheng YanHui
    Peng YouSong
    Huang WeiJuan
    Tan MinJu
    Wei HeJiang
    Guo JunFeng
    Wang DaYan
    Wu AiPing
    Shu YueLong
    Jiang TaiJiao
    SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (09) : 882 - 888
  • [2] Ineffectiveness of the 2014-2015 H3N2 influenza vaccine
    Mandelboim, Michal
    Glatman-Freedman, Aharona
    Drori, Yaron
    Sherbany, Hilda
    Pando, Rakefet
    Sefty, Hanna
    Zadka, Hila
    Shohat, Tamar
    Keller, Nathan
    Mendelson, Ella
    ONCOTARGET, 2016, 7 (02) : 1185 - 1192
  • [3] Antigenic variation of the human influenza A (H3N2) virus during the 2014–2015 winter season
    Sha Hua
    XiYan Li
    Mi Liu
    YanHui Cheng
    YouSong Peng
    WeiJuan Huang
    MinJu Tan
    HeJiang Wei
    JunFeng Guo
    DaYan Wang
    AiPing Wu
    YueLong Shu
    TaiJiao Jiang
    Science China Life Sciences, 2015, 58 : 882 - 888
  • [4] Antigenic variation of the human influenza A(H3N2) virus during the 2014–2015 winter season
    HUA Sha
    LI XiYan
    LIU Mi
    CHENG YanHui
    PENG YouSong
    HUANG WeiJuan
    TAN MinJu
    WEI HeJiang
    GUO JunFeng
    WANG DaYan
    WU AiPing
    SHU YueLong
    JIANG TaiJiao
    Science China(Life Sciences) , 2015, (09) : 882 - 895
  • [5] Antigenic Drift of A/H3N2/Virus and Circulation of Influenza-Like Viruses During the 2014/2015 Influenza Season in Poland
    Bednarska, K.
    Hallmann-Szelinska, E.
    Kondratiuk, K.
    Brydak, L. B.
    RESPIRATORY CONTAGION, 2016, 905 : 33 - 38
  • [6] Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses
    Duan, Wei
    Zhang, Li
    Wu, Shuangsheng
    Ma, Chunna
    Sun, Ying
    Zhang, Man
    Zhang, Yi
    Zhang, Xingxing
    Wang, Quanyi
    Yang, Peng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1031 - 1034
  • [7] Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance
    Roosenhoff, Rueshandra
    van der Vries, Erhard
    van der Linden, Anne
    van Amerongen, Geert
    Stittelaar, Koert J.
    Smits, Saskia L.
    Schutten, Martin
    Fouchier, Ron A. M.
    PLOS ONE, 2018, 13 (07):
  • [8] Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance
    Okomo-Adhiambo, Margaret
    Demmler-Harrison, Gail J.
    Deyde, Varough M.
    Sheu, Tiffany G.
    Xu, Xiyan
    Klimov, Alexander I.
    Gubareva, Larisa V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 1834 - 1841
  • [9] Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant
    Ruiz-Carrascoso, Guillermo
    Casas, Inmaculada
    Pozo, Francisco
    Gonzalez-Vincent, Marta
    Perez-Brena, Pilar
    ANTIVIRAL THERAPY, 2010, 15 (07) : 1059 - 1063